NCT03466411

Who might be able to join this trial:

• You have been diagnosed with Crohn's disease (including a form that causes tunnels or passages called fistulas) for at least 3 months, affecting your colon, small intestine, or both, confirmed at some point by imaging, tissue samples, or a camera procedure
• Your Crohn's disease is considered moderate to severe, based on scores measuring symptoms like stool frequency, abdominal pain, and the appearance of your intestines during a camera examination
• Your blood or lab test results from the screening stage fall within the acceptable ranges set by the study
• If you are a woman who could become pregnant, you must have a negative pregnancy test at the start of the study
• You have either not responded well enough to standard Crohn's disease treatments or biologic medicines, or you were unable to tolerate them

Who may not be able to join:

• You have been diagnosed with ulcerative colitis or a form of colitis that doctors have not been able to clearly classify
• You have serious complications from Crohn's disease, such as significant narrowing of the intestine, short gut syndrome, or other related complications
• Your current Crohn's disease medications have not been at a stable dose recently
• You have recently received certain approved biologic treatments, experimental treatments, or procedures outside of the timeframes allowed by the study rules
• You have other health conditions that would make it unsafe for you to take part in the study (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.